Recurrence of SRF Post Intravitreal Ranibizumab for Pediatric Choroidal Neovascularisation Secondary to Best Disease.
Ocul Immunol Inflamm. 2020 Oct 2;28(7):1149-1151. doi: 10.1080/09273948.2019.1648834. Epub 2019 Sep 11.
Ocul Immunol Inflamm. 2020.
PMID: 31509457